Oral anti-diabetic agents: how do they stand after the university group diabetes program (UGDP)?
D002986:Clinical Trials as Topic; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D008297:Male; D010629:Phenformin / Q000009:adverse effects; D014044:Tolbutamide / Q000009:adverse effects
D007004:Hypoglycemic Agents; D014044:Tolbutamide; D010629:Phenformin